[1]
Beuselinck, B. et al. 2020. Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors. Acta Oncologica. 59, 7 (Jul. 2020), 818–824. DOI:https://doi.org/10.1080/0284186X.2020.1750696.